Eton Pharmaceuticals, Inc. (ETON) KPIs and segments
Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –
KPIs & segments
Operating metrics and segments that drive Eton Pharmaceuticals's business
Eton Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product($M) | 37.6 | 18.9 | |||||||||||
Product Sales and Royalties($M) | 24.3 | 21.3 | 22.5 | 18.9 | 14.0 | 11.6 | 9.82 | 9.07 | 7.97 | 7.31 | 7.03 | ||
License($M) | 0 | 0 | 0 | 0 | 0 | 3.29 | 0 | 0.50 | 0 | 0 | 0 | 0 | |
Product($M) | 25.4 | 11.9 | |||||||||||
Product Sales and Royalties($M) | 14.7 | 13.1 | 7.86 | 11.9 | 7.40 | 6.48 | 6.07 | 5.63 | 5.01 | 4.63 | 4.40 | ||
License($M) | 0 | 0 | 0 | 0 | 0 | 2.46 | 0 | 0.23 | 0 | 0 | -1 | 0 | |
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?